|Combination of methotrexate plus a non–TNF inhibitor bDMARD or tsDMARD¶|Low/very low|PICO 6a.C2–4/C5§|p. 109, 117–28|
|Methotrexate monotherapy is conditionally recommended over:| | | |
|Leflunomide|Low|PICO 2a.C3|p. 18|
|Dual or triple csDMARD therapy¶|Moderate|PICO 4a.C1–C2|p. 46–9|
|Combination of methotrexate plus a TNF inhibitor¶|Low|PICO 6a.C1|p. 110|